Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PIVKA-II Combined With Alpha-Fetoprotein for Diagnostic and Prognostic Value of Hepatic Tumors in Infants: Protocol for a Multicenter, Observational Study

NCT03645655 is registered in ClinicalTrials.gov with Shanghai Children's Medical Center as lead sponsor.

NCT NCT03645655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03645655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PIVKA-II Combined With Alpha-Fetoprotein for Diagnostic and Prognostic Value of Hepatic Tumors in Infants: Protocol for a Multicenter, Observational Study
Lead sponsor
Shanghai Children's Medical Center
Phase
Observational
Overall status
Completed
Start date
October 1, 2018
Completion date
June 30, 2021
Enrollment
257 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic hemangioendothelioma, hepatoblastoma